Inquiry Basket
H-Asn-AMC, a peptide substrate widely utilized in biochemical and biomedical research, boasts a multitude of applications. Here are the four key applications: Enzyme Activity Assays: Serving as a staple in fluorometric assays for measuring aminopeptidases and other proteolytic enzymes, H-Asn-AMC stands at the forefront. As the enzyme cleaves the substrate, it liberates AMC (7-amino-4-methylcoumarin), a fluorescent marvel that can be precisely quantified. This method presents a straightforward yet sensitive approach to gauging enzyme kinetics and the efficacy of inhibitors, offering profound insights into molecular processes.
Drug Discovery: Embarking on the realm of drug discovery, H-Asn-AMC emerges as a pivotal tool for screening potential inhibitors targeting proteolytic enzymes. By monitoring the fluctuating fluorescence signals, researchers swiftly pinpoint compounds that exhibit potent enzyme inhibition. This expedited high-throughput screening methodology catalyzes the discovery of novel drug candidates, propelling advancements in therapeutic agent development.
Cellular Assays: Delving into live-cell assays, H-Asn-AMC unravels the intricacies of aminopeptidase regulation and activity within cellular milieus. Introducing the substrate into cultured cells, researchers embark on a real-time odyssey to monitor enzymatic dynamics using fluorescence microscopy or plate readers. This analytical voyage sheds light on the physiological significance of these enzymes in driving cellular processes, enhancing our comprehension of cellular intricacies.
Biotechnology: In the realm of biotechnology, H-Asn-AMC emerges as an indispensable asset for fine-tuning enzyme production and purification workflows. By leveraging this fluorogenic substrate to quantify enzyme activity, scientists optimize expression systems, purification techniques, and storage conditions. This meticulous evaluation ensures the generation of potent enzyme preparations tailored for industrial applications or cutting-edge research endeavors.
